Ivelin S. Georgiev
- Virology top 0.5%
- Molecular Biology top 5%
- Immunology top 2%
- Infectious Diseases top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- Bruce R. DonaldPeter D. KwongTongqing ZhouAmy C. AndersonJohn R. MascolaMichel C. NussenzweigGary J. NabelJohannes F. Scheid
- Topics
- HIV Research and Treatment (39 papers)Monoclonal and Polyclonal Antibodies Research (26 papers)Immune Cell Function and Interaction (17 papers)
- Partner nations
- United StatesSouth AfricaFrance
In The Last Decade
Ivelin S. Georgiev
74 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Virology 1.6k
- Molecular Biology 1.5k
- Immunology 1.1k
- Infectious Diseases 934
- Radiology, Nuclear Medicine and Imaging 822
Countries citing papers authored by Ivelin S. Georgiev
This map shows the geographic impact of Ivelin S. Georgiev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivelin S. Georgiev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivelin S. Georgiev more than expected).
Fields of papers citing papers by Ivelin S. Georgiev
This network shows the impact of papers produced by Ivelin S. Georgiev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivelin S. Georgiev. The network helps show where Ivelin S. Georgiev may publish in the future.
Co-authorship network of co-authors of Ivelin S. Georgiev
This figure shows the co-authorship network connecting the top 25 collaborators of Ivelin S. Georgiev. A scholar is included among the top collaborators of Ivelin S. Georgiev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivelin S. Georgiev. Ivelin S. Georgiev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 6 | |
| 3 | 2 | |
| 4 | 27 | |
| 5 | 1 | |
| 6 | 29 | |
| 7 | 4 | |
| 8 | 24 | |
| 9 | 27 | |
| 10 | 61 | |
| 11 | 16 | |
| 12 | 10 | |
| 13 | 1 | |
| 14 | 86 | |
| 15 | 28 | |
| 16 | 46 | |
| 17 | 12 | |
| 18 | 92 | |
| 19 | Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01breakdown → | 821 |
| 20 | 65 |
About Ivelin S. Georgiev
Ivelin S. Georgiev is a scholar working on Virology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 76 papers that have together received 3.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (39 papers), Monoclonal and Polyclonal Antibodies Research (26 papers) and Immune Cell Function and Interaction (17 papers). The work is most often cited by research in Virology (1.6k citations), Immunology (1.1k citations) and Infectious Diseases (934 citations). Ivelin S. Georgiev has collaborated with scholars based in United States, South Africa and France. Frequent co-authors include Bruce R. Donald, Peter D. Kwong, Tongqing Zhou, Amy C. Anderson, John R. Mascola, Michel C. Nussenzweig, Gary J. Nabel, Johannes F. Scheid, Yongping Yang and Ryan Lilien. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.